Cancer centers to qualify for ARRA financial incentives with meaningful use certification from the Drummond Group
ATLANTA, Feb. 25, 2011 /PRNewswire/ -- Elekta's MOSAIQ®* oncology electronic medical record (EMR) has received complete EMR certification. Complete EMR certification officially validates the Elekta software and enables eligible providers to qualify to demonstrate Stage 1 meaningful use under the HITECH Act.
Tested and certified under the Drummond Group's Electronic Health Records Office of the National Coordinator Authorized Testing and Certification Body (ONC-ATCB) program, the EMR software is Stage 1 compliant with criteria adopted by the Secretary of Health and Human Services. The complete certification of MOSAIQ makes it the first comprehensive, oncology EMR to receive this important certification.
"MOSAIQ is a popular solution in many of the world's leading cancer care facilities, so certification is a huge step for this software and puts our customers at the front of the line for incentive funds," says Todd Powell, Executive Vice President, Elekta Software. "We have worked to make MOSAIQ not only the most comprehensive, interoperable and robust solution available, but also equipped it to perform functions that all modern EMRs should have to increase efficiency in patient care. Certification is additional evidence of these efforts."
Drummond Group's ONC-ATCB 2011/2012 certification program tests and certifies that EMRs meet the meaningful use criteria for either eligible provider or hospital technology. In turn, healthcare providers using the EMR systems of certified vendors are qualified to receive federal stimulus monies available under the HITECH Act upon demonstrating meaningful use of the technology – a key component of the federal government's push to improve clinical care delivery through the adoption and effective use of EMRs by U.S. healthcare providers.
In addition to providing a certified EMR, Elekta offers custom programs through its STRATEGIQ™ consultative services to help clients prepare to demonstrate meaningful use.
"Whether an existing MOSAIQ user seeking to qualify for incentives or a new customer wanting to adopt the Elekta EMR solution, STRATEGIQ experts can conduct a thorough audit of a cancer center's operations, then provide an action plan specific to their needs," says Powell. "The oncology field requires specific workflows and processes unique to the profession, and it is important that sites – from practices with a single clinician to groups with more than 100 physicians – develop an implementation plan that ensures success."
Leveraging more than 20 years of leadership and expertise of IMPAC Medical Systems, MOSAIQ is the tool of choice to manage cutting-edge treatment centers. Learn more about the world's most widely used oncology EMR at www.elekta.com/MOSAIQ.
This EHR module is 2011/2012 compliant to prove meaningful use under the HITECH Act and is certified by an ONC-ATCB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments. MOSAIQ was certified February 25, 2011, Certification ID number 02252011-1018-6 for Clinical Quality Measures: NQF0013, NQF0024, NQF0028, NQF0038, NQF0041, NQF0385, NQF0387, NQF0389, NQF0421. No additional software used
*MOSAIQ® is a registered trademark of its manufacturer, IMPAC Medical Systems, Inc.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible. Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.